C Peters-Engl
About
In The Last Decade
C Peters-Engl
25 papers receiving 482 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 192
- Pathology and Forensic Medicine 130
- Reproductive Medicine 114
- Oncology 106
- Surgery 103
Countries citing papers authored by C Peters-Engl
This map shows the geographic impact of C Peters-Engl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Peters-Engl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Peters-Engl more than expected).
Fields of papers citing papers by C Peters-Engl
This network shows the impact of papers produced by C Peters-Engl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Peters-Engl. The network helps show where C Peters-Engl may publish in the future.
Co-authorship network of co-authors of C Peters-Engl
This figure shows the co-authorship network connecting the top 25 collaborators of C Peters-Engl. A scholar is included among the top collaborators of C Peters-Engl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Peters-Engl. C Peters-Engl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 27 | |
| 4 | 12 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 20 | |
| 8 | 10 | |
| 9 | 13 | |
| 10 | 24 | |
| 11 | 36 | |
| 12 | 21 | |
| 13 | TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer. | 12 |
| 14 | 30 | |
| 15 | 53 | |
| 16 | 14 | |
| 17 | Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer. | 14 |
| 18 | Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer. | 3 |
| 19 | 18 | |
| 20 | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.